Skip to main content
Caplight Logo









Micropoint Biotechnologies

Micropoint Biotechnologies

Private
ShenzhenHealthcare & Life Scienceshttps://www.micropointbio.com/

Last Round

Private Equity

Sep 11, 2018

Total Funding Raised

$12.03M

Company Overview

Micropoint Biotechnologies is a medical device company that develops, manufactures, and sells point-of-care diagnostic products based on microfluidic and MEMS technologies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Health IoT, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

point-of-care testingPOCTmicrofluidicslab-on-a-chipmedical diagnosticsin vitro diagnosticsIVDcoagulation monitoringimmunofluorescencediagnostic cartridgesrazor-and-blade modelclinical diagnosticsanticoagulation therapydiagnostic reagentsrapid testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Micropoint Biotechnologies Comparables

Compare Micropoint Biotechnologies with similar companies based on industry and business-model similarity.

Micropoint Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zhejiang Pushkang Biotechnology Co., Ltd.
83%
biosurfit
81%
RollingStone Co., Ltd.
81%

Micropoint Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquitySep 11, 2018
Early FundingDec 31, 2017
Private EquityJul 1, 2017
StrategicApr 1, 2016
Private EquityMar 1, 2016
Series B
Sep 21, 2011

Key People

Founding team and executive leadership

徐建群

Interim CFO

Executive Team

Micropoint Biotechnologies Investors

Notable investors and investment history

Micropoint Biotechnologies investors
InvestorRounds
Northern Light Venture CapitalSeries B
Qianhai Ark Asset ManagementPrivate Equity
Share CapitalPrivate Equity
Shenzhen Capital GroupSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2018

    $4.38M round with Share Capital and Qianhai Ark.

  • Dec 31, 2017

    Raised capital from Bohai Industrial Investment Fund.

Micropoint Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Micropoint Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Micropoint Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range26
Year Founded2007
Last FundingSep 11, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?